Overexpression of human BAG3P209L in mice causes restrictive cardiomyopathy.
Kenichi KimuraAstrid OomsKathrin Graf-RiesenMaithreyan KuppusamyAndreas UngerJulia SchuldJan DaerrAchim LotherCaroline GeisenLutz HeinSatoru TakahashiGuang LiWilhelm RöllWilhelm BlochPeter F M van der VenWolfgang A LinkeSean M WuPitter F HuesgenJörg HöhfeldDieter O FürstBernd K FleischmannMichael HessePublished in: Nature communications (2021)
An amino acid exchange (P209L) in the HSPB8 binding site of the human co-chaperone BAG3 gives rise to severe childhood cardiomyopathy. To phenocopy the disease in mice and gain insight into its mechanisms, we generated humanized transgenic mouse models. Expression of human BAG3P209L-eGFP in mice caused Z-disc disintegration and formation of protein aggregates. This was accompanied by massive fibrosis resulting in early-onset restrictive cardiomyopathy with increased mortality as observed in patients. RNA-Seq and proteomics revealed changes in the protein quality control system and increased autophagy in hearts from hBAG3P209L-eGFP mice. The mutation renders hBAG3P209L less soluble in vivo and induces protein aggregation, but does not abrogate hBAG3 binding properties. In conclusion, we report a mouse model mimicking the human disease. Our data suggest that the disease mechanism is due to accumulation of hBAG3P209L and mouse Bag3, causing sequestering of components of the protein quality control system and autophagy machinery leading to sarcomere disruption.
Keyphrases
- endothelial cells
- early onset
- quality control
- amino acid
- mouse model
- rna seq
- heart failure
- induced pluripotent stem cells
- binding protein
- single cell
- high fat diet induced
- protein protein
- oxidative stress
- ejection fraction
- late onset
- chronic kidney disease
- newly diagnosed
- endoplasmic reticulum stress
- cell proliferation
- poor prognosis
- young adults
- prognostic factors
- small molecule
- metabolic syndrome
- patient reported outcomes
- insulin resistance